Aytu Biopharma (AYTU) Research & Development (2016 - 2025)
Historic Research & Development for Aytu Biopharma (AYTU) over the last 12 years, with Q2 2025 value amounting to $216000.0.
- Aytu Biopharma's Research & Development fell 7927.06% to $216000.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $378000.0, marking a year-over-year decrease of 8546.71%. This contributed to the annual value of $1.3 million for FY2025, which is 5211.27% down from last year.
- Per Aytu Biopharma's latest filing, its Research & Development stood at $216000.0 for Q2 2025, which was down 7927.06% from $162000.0 recorded in Q1 2025.
- Over the past 5 years, Aytu Biopharma's Research & Development peaked at $4.8 million during Q2 2021, and registered a low of $162000.0 during Q1 2025.
- For the 5-year period, Aytu Biopharma's Research & Development averaged around $1.4 million, with its median value being $733500.0 (2023).
- In the last 5 years, Aytu Biopharma's Research & Development surged by 146468.53% in 2021 and then crashed by 8570.55% in 2023.
- Quarter analysis of 5 years shows Aytu Biopharma's Research & Development stood at $4.5 million in 2021, then crashed by 61.79% to $1.7 million in 2022, then crashed by 69.53% to $521000.0 in 2023, then grew by 0.19% to $522000.0 in 2024, then tumbled by 58.62% to $216000.0 in 2025.
- Its Research & Development stands at $216000.0 for Q2 2025, versus $162000.0 for Q1 2025 and $522000.0 for Q4 2024.